13F HOLDINGS REPORT
venBio Partners LLC
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0000905148-25-001748
Total Value
$123.6M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | PHARVARIS N V | PHVS | 4,289,304 | $67.3M | 54.50% |
| 2 | ALUMIS INC | ALMS | 2,787,398 | $17.1M | 13.85% |
| 3 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 489,194 | $16.2M | 13.14% |
| 4 | ACELYRIN INC | 00445A100 | 3,806,410 | $9.4M | 7.61% |
| 5 | ALX ONCOLOGY HLDGS INC | ALXO | 9,699,925 | $6.0M | 4.89% |
| 6 | LYELL IMMUNOPHARMA INC | LYEL | 7,102,190 | $3.8M | 3.09% |
| 7 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 1,198,975 | $3.6M | 2.91% |